Tasigna Atherosclerosis and Cardiovascular Injury Lawyers
Tasigna (nilotinib) is a type of chemotherapy drug used to treat patients with chronic myelogenous leukemia (CML), a specific type of blood cancer that often requires a lifetime of costly treatment. Approved for use by the U.S. Food and Drug Administration in 2007, the drug slows or even stops abnormal cell growth.
While the results of the drug have been positive for many patients suffering from CML, the drug’s manufacturer failed to warn U.S. patients of severe—or even fatal—cardiovascular risks associated with Tasigna, including atherosclerosis, a disease that increases the likelihood of heart attacks and strokes. If you or a loved one were prescribed Tasigna and suffered atherosclerosis, cardiovascular complications, or limb amputations, Ferrer, Poirot & Wansbrough wants to help protect your rights.
Our attorneys have more than 35 years of experience handling drug injury claims on behalf of victims and their families, and we’re here to help you get the compensation you deserve. Contact us 24/7 for a free, no-obligation case review—just dial (800) 210-8503 or complete our free online form to get started.
Atherosclerosis Linked to Severe Side Effects in Tasigna Patients
Use of Tasigna has been linked to atherosclerosis, a disease caused by thickening and hardening of plaque buildup in the arteries. The plaque, made up of fatty deposits and cells that collect in arteries over time, narrows and hardens the passageways blood must flow through to maintain a healthy cardiovascular system. As a result, patients who suffer from atherosclerosis are at an increased risk of heart attack and stroke.
Other side effects related to atherosclerosis in Tasigna clinical trials include:
- Peripheral arterial occlusive disease (hardening and narrowing of the arteries that supply blood to the arms and legs)
- Femoral artery stenosis (hardening and narrowing of the arteries located in the upper thigh)
- Coronary artery stenosis (hardening or narrowing of the arteries supplying the heart)
- Carotid artery stenosis (hardening or narrowing of the carotid artery in the neck)
- Cerebrovascular accident (stroke)
- Limb amputation
Our drug injury lawyers are here to hold the drug manufacturer accountable for their negligence if you or a loved one suffered atherosclerosis or cardiovascular side effects after taking Tasigna. We understand the physical and emotional strain a CML diagnosis places upon families, and we don’t think it’s right that unknowing patients faced serious cardiovascular risks while taking Tasigna.
Free Tasigna Case Review From Our 24/7 Legal Team
Ferrer, Poirot & Wansbrough is currently investigating atherosclerosis, cardiovascular disease, and limb amputation cases linked to Tasigna. If you or a loved one were diagnosed with chronic myelogenous leukemia and suffered any of these serious complications after taking Tasigna, our lawyers are ready to review your potential claim—24 hours a day, 7 days a week. Dial (800) 210-8503 or complete our free online form to get help now.
Tasigna® is a registered trademark of Novartis AG and is used here only to identify the product in question. This law firm is not associated with, sponsored by, or affiliated with Novartis AG or the U.S. Food and Drug Administration.
Do not stop taking a prescription medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death.
Cases may be referred to another attorney or law firm.